Cibus Confirms NASDAQ Listing for Class A Common Stock

TL;DR

**Cibus 8-K confirms NASDAQ listing for CBUS, no new material info.**

AI Summary

Cibus, Inc. filed an 8-K on January 9, 2024, primarily to disclose that its Class A Common Stock, with a par value of $0.0001 per share, is registered for trading on The NASDAQ Stock Market LLC under the trading symbol CBUS. This filing also confirms Cibus's corporate details, including its Delaware incorporation and San Diego business address. For investors, this filing is a routine update confirming the company's listing status and basic corporate information, indicating no immediate material changes that would significantly impact the stock's value.

Why It Matters

This filing confirms Cibus, Inc.'s listing on NASDAQ, providing transparency on where its shares are traded. It's a standard disclosure that assures investors of the stock's public trading venue.

Risk Assessment

Risk Level: low — This 8-K filing is a routine disclosure of corporate information and does not contain any new material events that would introduce significant risk.

Analyst Insight

A smart investor would note this as a routine administrative filing that provides no new material information to act upon. It simply confirms existing public knowledge about the company's stock listing.

Key Numbers

• $0.0001 — par value per share (the stated par value of Cibus's Class A Common Stock)

Key Players & Entities

• Cibus, Inc. (company) — the registrant filing the 8-K
• The NASDAQ Stock Market LLC (company) — the exchange where Cibus's Class A Common Stock is registered
• $0.0001 (dollar_amount) — par value per share of Class A Common Stock
• January 9, 2024 (date) — date of earliest event reported and filing date
• CBUS (company) — trading symbol for Cibus, Inc. Class A Common Stock

FAQ

Key Financial Figures

• $0.0001 — which registered Class A Common Stock, $0.0001 par value per share CBUS The NASDAQ Sto

Filing Documents

• cbus-20240109.htm (8-K) — 34KB
• wheatpr_jan92024xfinal.htm (EX-99.1) — 24KB
• image_0.jpg (GRAPHIC) — 5KB
• 0001628280-24-000957.txt ( ) — 198KB
• cbus-20240109.xsd (EX-101.SCH) — 2KB
• cbus-20240109_lab.xml (EX-101.LAB) — 23KB
• cbus-20240109_pre.xml (EX-101.PRE) — 12KB
• cbus-20240109_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On January 9, 2024, Cibus, Inc. (" Cibus " or the " Company ") issued a press release. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed to be "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of such section, nor shall such information be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the " Securities Act "), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Other Events

Item 8.01. Other Events. On January 9, 2024, the Company announced that it has successfully regenerated plants from single cells in a wheat cultivar. This is a major breakthrough for Cibus and opens a scalable gene editing process in wheat. This achievement enables the prototyping of productivity and quality traits to address this crop's key challenges potentially providing farmers with new tools to manage their farm and improve their profitability. Cibus intends to develop a family of traits to address the most significant challenges faced by farmers globally for wheat, focusing initially on disease resistance and nitrogen use efficiency.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding Cibus' operational and financial performance, Cibus' strategy, future operations, prospects and plans, including the anticipated regulatory environment are forward-looking statements. Forward-looking statements may be identified by words such as "anticipate," "believe," "intend", "expect," "plan," "scheduled," "could," "would" and "will," or the negative of these and similar expressions. These forward-looking statements are based on the current expectations and assumptions of Cibus' management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. Cibus' actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: changes in expected or existing competition; challenges to Cibus' intellectual property protection and unexpected costs associated with defending intellectual property rights; increased or unanticipated time and resources required for Cibus' platform or trait product development efforts; Cibus' reliance on third parties in connection with its development activities; challenges associated with Cibus' ability to effectively license its productivity traits and sustainable ingredient products; the risk that farmers do not recognize the value in germplasm containing Cibus' traits or that farmers and processors fail to work effectively with crops containing Cibus' traits; challenges that arise in respect

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated January 9, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 9, 2024 CIBUS, INC. By: /s/ Rory Riggs Name: Rory Riggs Title: Chief Executive Officer and Chairman

View Full Filing

View this 8-K filing on SEC EDGAR